Repligen Corporation

The Latest in Medical Innovation: Repligen Corporation Introduces Revolutionary Tangential Flow Filtration System

TangenX SC: The First of Its Kind

WEB Repligen Corporation has announced the groundbreaking launch of TangenX SC, the industry's first holder-free, self-contained Tangential Flow Filtration (TFF) system. This revolutionary technology represents a significant advancement in bioprocessing, offering numerous benefits for the production of biological drugs.

Benefits of TangenX SC

• Eliminates Holder Requirements: Unlike traditional TFF systems, TangenX SC operates without the need for bulky and costly holders, reducing equipment size and maintenance.
• Enhanced Efficiency: Its unique design enables higher feed rates and improved filtration efficiency, leading to increased productivity.
• Simplified Operation: The self-contained system simplifies operation, reducing operator training and potential errors.

State-of-the-Art Technology

TangenX SC embodies the latest advances in biotechnology. Its proprietary membrane technology provides precise and efficient filtration, ensuring high product quality and purity. The system's robust design and advanced controls ensure reliable and consistent performance.

Applications in Bioprocessing

TangenX SC is ideally suited for a wide range of applications in bioprocessing, including:

• Purification of Monoclonal Antibodies: Removes impurities and concentrates monoclonal antibodies.
• Diafiltration and Buffer Exchange: Efficiently exchanges buffers and removes salts from protein solutions.
• Virus Inactivation: Inactivates viruses and other contaminants, enhancing product safety.

Commitment to Innovation

The launch of TangenX SC underscores WEB Repligen's commitment to innovation and providing cutting-edge solutions for the bioprocessing industry. With its dedication to advancing scientific research and improving patient outcomes, WEB Repligen remains a trusted partner for pharmaceutical and biotechnology companies worldwide.

Conclusion

TangenX SC's revolutionary design has the potential to transform the bioprocessing industry. Its holder-free, self-contained operation, enhanced efficiency, and simplified operation make it an indispensable tool for manufacturers seeking to produce high-quality biological drugs with greater efficiency and cost-effectiveness. As the industry embraces this groundbreaking technology, WEB Repligen continues to demonstrate its leadership in delivering innovative solutions that drive progress in healthcare.